We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69B
$69B $21.59 0.75%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$49.7B
$49.7B $42.57 4.34%
HLN icon
3
Haleon
HLN
$40.4B
$40.4B $9.20 0.33%
ZTS icon
4
Zoetis
ZTS
$34.3B
$34.3B $84.39 0.68%
UTHR icon
5
United Therapeutics
UTHR
$25B
$25B $587.88 0.56%
VTRS icon
6
Viatris
VTRS
$23.8B
$23.8B $20.74 0.38%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.7B
$16.7B $165.31 1.25%
ELAN icon
8
Elanco Animal Health
ELAN
$13.2B
$13.2B $26.41 1.38%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.3B
$12.3B $14.70 0.27%
ALKS icon
10
Alkermes
ALKS
$7.82B
$7.82B $46.53 1.06%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.4B
$7.4B $94.23 2.18%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.4B
$7.4B $21.23 0.7%
LNTH icon
13
Lantheus
LNTH
$6.65B
$6.65B $101.72 0.13%
SUPN icon
14
Supernus
SUPN
$5.99B
$5.99B $28.83 2.99%
LQDA icon
15
Liquidia
LQDA
$5.08B
$5.08B $56.37 1.81%
HIMS icon
16
Hims & Hers Health
HIMS
$4.35B
$4.35B $18.56 5.93%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.57B
$3.57B $27.80 8.22%
BHC icon
18
Bausch Health
BHC
$3.15B
$3.15B $8.42 0.84%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.05B
$3.05B $16.70 0.24%
HCM icon
20
HUTCHMED
HCM
$2.56B
$2.56B $14.73 1.14%
RGC icon
21
Regencell Bioscience
RGC
$2.34B
$2.34B $4.72 4.45%
PBH icon
22
Prestige Consumer Healthcare
PBH
$2.28B
$2.28B $48 3.92%
PRGO icon
23
Perrigo
PRGO
$2.25B
$2.25B $16.18 0.37%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.92B
$1.92B $7.45 2.1%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.84B
$1.84B $63.88 0.08%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $371B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69B, Teva Pharmaceutical Industries (TEVA) at $49.7B and Haleon (HLN) at $40.4B.

Among institutional investors, Trulieve Cannabis (TRLV) drew the most net new fund positions in Q2 2026: 123 funds opened new positions, taking total fund holders up 121 (2,017%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.